Filing Details
- Accession Number:
- 0001232524-17-000150
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-14 17:29:46
- Reporting Period:
- 2017-08-10
- Filing Date:
- 2017-08-14
- Accepted Time:
- 2017-08-14 17:29:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1232524 | Jazz Pharmaceuticals Plc | JAZZ | Pharmaceutical Preparations (2834) | 981032470 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1615762 | Elmar Schnee | 5Th Fl, Waterloo Exchange Waterloo Rd Dublin 4 L2 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2017-08-10 | 1,365 | $0.00 | 6,540 | No | 4 | A | Direct | |
Ordinary Shares | Disposition | 2017-08-11 | 1,194 | $142.36 | 5,346 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2017-08-11 | 3 | $144.20 | 5,343 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2017-08-11 | 2 | $144.13 | 5,341 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Non-Qualified Stock Option (right to buy) | Acquisiton | 2017-08-10 | 3,415 | $0.00 | 3,415 | $143.66 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,415 | 2027-08-09 | No | 4 | A | Direct |
Footnotes
- These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2018.
- Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2017.